ArabFinance: October Pharma's ordinary general assembly (OGM) approved, on April 8th, cash dividends of EGP 3 per share, according to the company disclosure filed to the Egyptian Exchange.
The OGM decided to postpone the stock dividends decision for more investigation.
The extraordinary general assembly ratified amending some articles of the company's articles of association.
October Pharma reported a net profit of EGP 88.26 in 2020, a 161% rise from EGP 33.8 million achieved in 2019.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.
The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.
